Healius Limited (ASX:HLS)
0.8670
-0.0030 (-0.34%)
Nov 7, 2025, 10:36 AM AEST
Healius Company Description
Healius Limited provides medical laboratory and pathology services in Australia.
The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands.
It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018.
Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Healius Limited
| Country | Australia |
| Founded | 1994 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 8,224 |
| CEO | Paul Anderson |
Contact Details
Address: 161 Castlereagh Street Sydney, Victoria 2000 Australia | |
| Phone | 61 2 9432 9400 |
| Website | healius.com.au |
Stock Details
| Ticker Symbol | HLS |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000033359 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Paul D. Anderson B.Com., C.A. | MD, Chief Executive Officer and Director |
| Puneet Nagi M.B.A. | Chief Operating Officer |
| Prasad Arav | Group Executive of Digital and Technology and Strategy |
| Sharon Ng | Head of FP&A and Investor Relations |
| Kylie Brown | Group General Counsel, Company Secretary and Chief Risk Officer |
| Paula Bayliss | Group Executive of People and Culture |
| John McKechnie | Advisor |
| Dr. Phil Lucas | Chief Executive of Lumus Imaging |
| Ian Mcphan | Chief Operating Officer of Healius Pathology |
| Dr. Jan Van Rooyen | Head and Group Executive of Healius Pathology |